Evidence map›Paper›PMID 39853494›Full record

ArticleArchives of microbiology2025

Unveiling Paramyrothecium kamalii (Stachybotryaceae) as a novel foliar fungal pathogen on Matourea azurea in Kerala, India, based on morpho-cultural, pathological and molecular phylogenetic evidences.

Shambhu Kumar, K B Farsana, K T Mufeeda, Raghvendra Singh, S Mahadevakumar

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shambhu KumarForest Pathology Department, KSCSTE-Kerala Forest Research Institute, Peechi, Thrissur, Kerala, 680653, India. skumartaxon@gmail.com.ORCID http://orcid.org/0000-0001-9534-9309
K B FarsanaForest Pathology Department, KSCSTE-Kerala Forest Research Institute, Peechi, Thrissur, Kerala, 680653, India.ORCID http://orcid.org/0009-0005-8109-7186
K T MufeedaForest Pathology Department, KSCSTE-Kerala Forest Research Institute, Peechi, Thrissur, Kerala, 680653, India.ORCID http://orcid.org/0009-0001-2625-2746
Raghvendra SinghCentre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India.ORCID http://orcid.org/0000-0002-8672-6149
S MahadevakumarAndaman and Nicobar Regional Centre, Botanical Survey of India, Haddo, Port Blair, 744102, India.ORCID http://orcid.org/0000-0002-8611-7503

Funding

Science and Engineering Research Board CRG/2019/005014
6 · The paper itself

Abstract

During recent survey for the investigation of foliar fungi in Kerala, India, a new species of foliicolous hyphomycete, Paramyrothecium kamalii was discovered on living leaves of Matourea azurea (Plantaginaceae) based on morpho-cultural characteristics and multigene (ITS, LSU, cmdA, tub2, and rpb2) phylogenetic analysis; is described, illustrated and discussed. In vitro Pathogenicity tests were performed and confirmed the pathogenic nature of the fungus, thereby fulfilling Koch's postulates. Phylogenetically, P. kamalii forms a distinct clade, closely related to P. verroridum, P. indicum, and P. roridum. However, it differs morphologically by having longer conidiophores and conidia and lacks setae, unlike the closer species. The identification of P. kamalii as a new foliar pathogen provides critical insights for surveillance and effective control measure of this foliar disease of M. azurea in tropical ecosystems.

Indexed as

AscomycotaPhylogenyPlant DiseasesPlant LeavesDNA, FungalIndiaSpores, FungalDNA, FungalFoliicolousFungiMultigene-phylogenyNew speciesTaxonomy

Identifiers

PMID39853494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.